Connect with us:

Facebook Twitter RSS

General resources

Welcome Eurocan Platform Kick-off

A Platform of European Cancer Research Centres for Translational Research - Powerpoint presentation (4MB)

 

Standard Operating Procedures - WP3 Early detection/biomarker discovery

 

WP10 Biobanking documents on Quality and procedures biobanks for the EurocanPlatform consortium

Visit this link for documents relating work from WP10 -  Biobanking:

http://www.tubafrost.org/research/indexeuro1.php

 

World Cancer Day article featured in European Parliament Magazine

An article featuring Prof. Julio Celis in the European Parliament Magaze, disccussing the importance of European research.

 

News from EurocanPlatform - February updates and announcements

Latest project updates and announcements.

 

Publications acknowledging EurocanPlatform

Publications from within the project from Year 2.

 

News from EurocanPlatform - March 2012 updates and announcements

 

News from EurocanPlatform - May 2012 updates and announcements

Project updates and announcements.

 

News from EurocanPlatform - September 2012

 

Platform to identify tumour markers at EurocanPlatform Partner institutes

 

http://ecancer.org/institute/eurocanplatform/tumour-markers.php

 

EAPM Members Update: Discussion on Data Protection legislation

EAPM highlights Data Protection legislation issues at ENVI Committee meeting, 6th June

 

EurocanPlatform Fact Sheet

EurocanPlatform Fact Sheet: background, partner list and contact details.

 

EurocanPlatform Clinical Trial Platform

Details of and link to the EurocanPlatform clinical trials platform, hosted on ecancer.org

 

Science policy paper published in Molecular Oncology

New journal article by Julio Celis, published in May 2014 in the journal Molecular Oncology.

Authors: Celis JE & Gago JM

Abstract

The Lisbon Strategy was adopted by the Heads of State and Government of the European Union (EU) in 2000. By moving science into a central position for the development of a European knowledge-based economy and society, its adoption at political level seems to have been a powerful catalyst for the increased involvement of scientists in science policy in the EU. Recognising the need for scientists to act collectively in order to contribute to shape the future of science policy in Europe, a pioneering group of European science organisations leaders and representatives, as well as other scientists, initiated a European, interdisciplinary, inclusive movement leading to the creation of the European Research Council (ERC) to support basic research of the highest quality. Having scientists' campaign for the funding of bottom-up research by the EU Framework Programmes exclusively on scientific grounds, and for an ERC, was a unique event in the recent history of European science policy. For the first time, the scientific community acted collectively and across disciplinary or national boundaries as a political actor for the sake of a better science policy for Europe. As is often the case when first-hand experience is gained through the creation of a new organization, novel forms of collaboration arise. The European biomedical community has recently proposed the creation of a strategic action plan for health research (the European Council of Health Research; EuCHR), provisionally translated at present into a Scientific Panel for Health (SPH) research in Horizon 2020, the EU's research-funding programme for the period 2014-2020. The creation of such Scientific Panel should be viewed as an important contribution by the biomedical community as a major political agreement has been reached on the need for a comprehensive and long-term scientific strategy to accelerate research and facilitate innovation at EU level. It is our belief that describing and analyzing the process leading to the creation of the ERC and SPH (2002-2014) should be widely shared with the research community in general, as this may contribute to the understanding of the evolving relations between scientists and science-policy making.

Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

 

Link to the full article on PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24726457

 

Biobanking FAQs

The European Cancer Patient Coalition (ECPC) has put together a Glossary and a set of Frequently Asked Questions with regards to biobanking.

 


Events

Inventory of Translational Cancer Research Courses

 

In the EurocanPlatform project, a deliverable of the 'Education and Training' Work Package, being lead by Instituto Tumori Giovanni Paolo II, was to complete an inventory of the translational cancer research educational programmes offered by ECCO, EORTC, ESTRO, ESO, OECI and ESMO. This inventory has been completed and available programmes can be viewed in the ecancer events calendar. This is a PDF list of the courses.


 


Partner information

OECI newsletter No.2 June 2012

The OECI has published its 2nd newsletter of 2012.

 



Useful links »

Video

Video

Watch interviews with key experts involved in the project.